Evidence map›Paper›PMID 40377094›Full record

ArticleNucleic acids research2025

Onkopus: precise interpretation and prioritization of sequence variants for biomedical research and precision medicine.

Nadine S Kurz, Kevin Kornrumpf, Tim Tucholski, Klara Drofenik, Alexander König, Tim Beißbarth, Jürgen Dönitz

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nadine S KurzDepartment of Medical Bioinformatics, University Medical Center Göttingen, 37077 Göttingen, Germany.ORCID 0000-0001-8857-1534
Kevin KornrumpfDepartment of Medical Bioinformatics, University Medical Center Göttingen, 37077 Göttingen, Germany.ORCID 0009-0007-3229-8592
Tim TucholskiDepartment of Medical Bioinformatics, University Medical Center Göttingen, 37077 Göttingen, Germany.ORCID 0009-0003-9682-0774
Klara DrofenikDepartment of Medical Bioinformatics, University Medical Center Göttingen, 37077 Göttingen, Germany.ORCID 0009-0002-3002-8429
Alexander KönigDepartment of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Center Göttingen, 37075 Göttingen, Germany.
Tim BeißbarthDepartment of Medical Bioinformatics, University Medical Center Göttingen, 37077 Göttingen, Germany.ORCID 0000-0001-6509-2143
Jürgen DönitzDepartment of Medical Bioinformatics, University Medical Center Göttingen, 37077 Göttingen, Germany.ORCID 0000-0002-8401-8851

Funding

Deutsche Forschungsgemeinschaft 01KD2208ADeutsche Forschungsgemeinschaft 01KD2401BDeutsche Forschungsgemeinschaft 01KD2414ADeutsche Forschungsgemeinschaft 01KD2437Deutsche Forschungsgemeinschaft KFO5002Deutsche Krebshilfe 70114018Gemeinsamer Bundesauschuss 01NVF20006Göttingen UniversityVolkswagen Foundation 11-76251-12-1/19
6 · The paper itself

Abstract

One of the major challenges in precision oncology is the identification of pathogenic, actionable variants and the selection of personalized treatments. We present Onkopus, a variant interpretation framework based on a modular architecture, for interpreting and prioritizing genetic alterations in cancer patients. A multitude of tools and databases are integrated into Onkopus to provide a comprehensive overview about the consequences of a variant, each with its own semantic, including pathogenicity predictions, allele frequency, biochemical and protein features, and therapeutic options. We present the characteristics of variants and personalized therapies in a clear and concise form, supported by interactive plots. To support the interpretation of variants of unknown significance (VUS), we present a protein analysis based on protein structures, which allows variants to be analyzed within the context of the entire protein, thereby serving as a starting point for understanding the underlying causes of variant pathogenicity. Onkopus has the potential to significantly enhance variant interpretation and the selection of actionable variants for identifying new targets, drug screens, drug testing using organoids, or personalized treatments in molecular tumor boards. We provide a free public instance of Onkopus at https://mtb.bioinf.med.uni-goettingen.de/onkopus.

Indexed as

Genetic VariationNeoplasmsPrecision MedicineSoftwareBiomedical ResearchDatabases, GeneticHumans

Identifiers

PMID40377094
PMCPMC12230665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.